Angiotensin blockade in children with chronic glomerulonephritis and heavy proteinuria

Pediatric Nephrology

Volumn 20, Issue 11, 2005, Pages 1651-1654

  Butani, Lavjay ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACE inhibition; ARB; Dual therapy; IgA nephropathy; MPGN; Pediatric

Indexed keywords

ALBUMIN; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FISH OIL; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT; LISINOPRIL; LOSARTAN; VALSARTAN;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DEMOGRAPHY; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HEALTH PRACTITIONER; HEALTH PROMOTION; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LABORATORY TEST; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RENOVASCULAR HYPERTENSION; TREATMENT OUTCOME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; PROTEINURIA; REMISSION INDUCTION;

EID: 27644563929     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2031-5     Document Type: Article

References (10)

1. Giri S, Mahajan SK, Sen R, Sharma A (2002) Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency. J Assoc Physicians India 50:1245-1249 12568207
2. Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E (2003) Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial. J Am Soc Nephrol 14:1578-1583 10.1097/ 01.ASN.0000068460.37369.DC
3. Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM (2001) Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 38:18-25 11431176
4. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial. Lancet 361:117-124 10.1016/ S0140-6736(03)12229-5
5. Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S (2004) Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. Pediatr Int 46:576-579 10.1111/j.1442-200x.2004.01955.x
6. Bhattacharjee R, Filler G (2002) Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy. Pediatr Nephrol 17:302-304 10.1007/s00467-002-0829-y
7. Butani L (2003) Remission of membranoproliferative nephritis with angiotensin converting enzyme inhibition and receptor blockade. Pediatr Nephrol 18:1199 10.1007/s00467-003-1296-9
8. Tarshish P, Bernstein J, Tobin JN, Edelmann CM, Jr. (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone - a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123-130 10.1007/BF00866289
9. Schieppati A, Remuzzi G (2003) The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: Frustration and promises. Kidney Int 64:1947-1955 10.1046/j.1523-1755.2003.00340.x
10. Klahr S, Morrissey J (2002) Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. Kidney Int Suppl 23-26